Janus Henderson Global Life Sciences Fund Class N Shares
Janus Henderson Global Life Sciences Fund Class N Shares (JFNNX)
This fund endeavors to meet its investment goals by typically committing a minimum of 80% of its net assets (including any borrowed capital used for investment) to companies its portfolio managers determine have a primary focus on life sciences. Moreover, a core tenet of the fund's approach to life science enterprises is a fundamental policy to ordinarily allocate at least 25% of its total assets to businesses formally classified within the "life sciences" sector.
JFNNX Mutual Fund Chart & Stats
- Previous Close
- $93.44
- Sub-Category
- Global,International
- Total Liabilities
- $11.19M
- Last Dividend Ex-Date
- Dec 05, 2025
- Expense Ratio
- 0.68%
- Holding Count
- 84
- Brand
- Janus Investment Fund
- Dividend Yield
- (4.03%)
- Category
- Equity
- Total Assets
- 5.82B
- Shares Outstanding
- N/A
- 52-Week Range
- $75.29 - $95.64
JFNNX Mutual Fund News
Praxis Precision Medicines: Late-Stage Pipeline and Regulatory Catalysts Support Buy Rating
JonesTrading analyst Justin Walsh has reiterated their bullish stance on PRAX stock, giving a Buy rating today. Justin Walsh gave his rating based on several factors, including continued execution across
JFNNX Mutual Fund Smart Score
Top 10 Holdings
| Name | Weight % |
|---|---|
| LLYEli Lilly And Company | 9.41% |
| JNJJohnson & Johnson | 7.09% |
| ABBVAbbvie | 4.67% |
| UNHUnitedhealth Group Inc. | 4.54% |
| AZNAstraZeneca plc | 3.93% |
| RVMDRevolution Medicines, Inc. | 3.02% |
| ARGXArgenx | 2.63% |
| NVSNovartis AG | 2.56% |
| TMOThermo Fisher Scientific | 2.33% |
| PRAXPraxis Precision Medicines, Inc. | 2.19% |
| Total | 42.37% |
Recently Viewed
No data currently available





